Strides to exit investment in Arrow for AUD 394 mn

Strides to exit investment in Arrow for AUD 394 mn The company#39;s step-down subsidiary Strides Pharma Global Pte Ltd has approved the sale of its entire Australian business to the Arrow-Apotex merged entity, Strides Pharma Science said in a filing to the BSE.

No comments:

Post a Comment